Healio Disruptive Innovators Awards 2024
Take this survey powered by surveymonkey.com. Create your own surveys for free.
Related Articles
Q-TWiST Analysis Assesses Progression/Toxicity of Belzutifan Vs Everolimus in ccRCC
Results from a Q-TWiST analysis of the LITESPARK-005 trial showed a trend favoring belzutifan over everolimus for patients with clear cell RCC.
Cancer misinformation on social media
CA: A Cancer Journal for Clinicians is ACS’ flagship clinical oncology journal publishing information about the prevention, early detection, and treatment of cancer.
Sun Protection
No single method of sun protection can safeguard you perfectly. A complete strategy is the best way to protect yourself against skin cancer.
Healio Disruptive Innovators Awards 2024
Take this survey powered by surveymonkey.com. Create your own surveys for free.
Amid alarming spike in early-onset colorectal cancer, ‘driving force’ remains elusive
An analysis of SEER registry data published in 2003 revealed for the first time a troubling rise in colorectal cancer among young adults in the…
Healio Disruptive Innovators Awards 2024
Take this survey powered by surveymonkey.com. Create your own surveys for free.
Volunteering
Volunteers are important members of the Huntsman Cancer Institute (HCI) team. Volunteer opportinities include comforting patients and their families, working with various HCI services, assisting…
Dissecting JAK2V617F’s double life with and without MPL
In this issue of Blood, Papadopoulos et al delineate myeloproliferative leukemia virus oncogene (MPL)-dependent and -independent phenotypes of JAK2V617F+ m
Aerobic exercise and CogniTIVe functioning in women with breAsT cancEr (ACTIVATE): A randomized controlled trial
As the prevalence and consequences of chemotherapy-related cognitive impairment rise, investigation into treatment options for patients is critical. Findings of this randomized controlled trial suppo…
